Research graph
References from Percutaneous Fine-Needle 5% Ethanol-Cisplatin Intratumoral Injection Combined with Second-Line Chemotherapy Improves On the Standard of Care in Patients with Platinum-Pretreated Stage IV Non–Small Cell Lung Cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
Randomized phase III trial of pemetrexed versus docetaxel in patients with non–small-cell lung cancer previously treated with chemotherapy
10.1200/jco.2004.08.163 · 2004 · External reference
Clinical cancer advances 2012: annual report on progress against cancer from the American Society of Clinical Oncology
10.1200/jco.2012.47.1938 · 2013 · External reference
Low molecular weight heparin ablates lung cancer cisplatin-resistance by inducing proteasome-mediated ABCG2 protein degradation
10.1371/journal.pone.0041035 · 2012 · External reference
Tumour stem cells and drug resistance
10.1038/nrc1590 · 2005 · External reference
Erlotinib or gefitinib for the treatment of relapsed platinum pretreated non-small cell lung cancer and ovarian cancer: a systematic review
10.1016/j.drup.2011.02.004 · 2011 · External reference
Screening for epidermal growth factor receptor mutations in lung cancer
10.1056/nejmoa0904554 · 2009 · External reference
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial
10.1016/s0140-6736(08)61758-4 · 2008 · External reference
Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study
10.1016/s1470-2045(11)70385-0 · 2012 · External reference
Optimal chemotherapy treatment for women with recurrent ovarian cancer
10.3747/co.2007.148 · 2007 · External reference
Cisplatin in 5% ethanol eradicates cisplatin-resistant lung tumor by killing lung cancer side population cells and non-SP cells
10.3389/fgene.2013.00163 · 2013 · External reference
Cord blood-derived cytokine-induced killer cells biotherapy combined with second-line chemotherapy in the treatment of advanced solid malignancies
10.1016/j.intimp.2010.12.014 · 2011 · External reference
Intratumoral injection of BCNU in ethanol (DTI-015) results in enhanced delivery to tumor—a pharmacokinetic study
10.1007/s11060-004-5675-2 · 2005 · External reference
Tissue platinum concentration and tumor response in non–small-cell lung cancer
10.1200/jco.2011.40.8120 · 2012 · External reference
Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study
10.1016/s1470-2045(12)70489-8 · 2013 · External reference
DTI-015 produces cures in T9 gliosarcoma
10.1016/s1476-5586(03)80013-1 · 2003 · External reference
Stereotactic injection of DTI-015 into recurrent malignant gliomas: phase I/II trial
10.1016/s1476-5586(03)80012-x · 2003 · External reference
Phase II trial of intratumoral BCNU injection and radiotherapy on untreated adult malignant glioma
10.1007/s11060-010-0113-0 · 2010 · External reference
Chronic alcohol consumption stimulates VEGF expression, tumor angiogenesis and progression of melanoma in mice
10.4161/cbt.6.8.4406 · 2007 · External reference
Percutaneous cryoablation for the treatment of medically inoperable stage I non-small cell lung cancer
10.1371/journal.pone.0033223 · 2012 · External reference
